Inotropic Drugs for the Treatment of Heart Failure
- 1 October 1985
- journal article
- review article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 25 (7) , 540-554
- https://doi.org/10.1177/009127008502500710
Abstract
No abstract availableThis publication has 96 references indexed in Scilit:
- Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart FailureNew England Journal of Medicine, 1984
- Beneficial Hemodynamic Effects of Oral Levodopa in Heart FailureNew England Journal of Medicine, 1984
- Evaluation of a New Bipyridine Inotropic Agent — Milrinone — in Patients with Severe Congestive Heart FailureNew England Journal of Medicine, 1983
- Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure.Circulation, 1983
- Peripheral dopamine receptors, potential targets for a new class of antihypertensive agents: Part I: Subclassification and functional descriptionLife Sciences, 1982
- Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human HeartsNew England Journal of Medicine, 1982
- Decreased Lymphocyte Beta-Adrenergic-Receptor Density in Patients with Heart Failure and Tolerance to the Beta-Adrenergic Agonist PirbuterolNew England Journal of Medicine, 1981
- BromocriptineNew England Journal of Medicine, 1979
- Dobutamine: A New Synthetic Cardioactive Sympathetic AmineNew England Journal of Medicine, 1979
- Hemodynamic Assessment of AmrinoneNew England Journal of Medicine, 1978